Cassia Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
6,185
-145
| -2% | -$26.9K | 0.69% | 31 |
|
|
2025
Q1 | $1.33M | Buy |
6,330
+272
| +4% | +$57K | 0.83% | 19 |
|
|
2024
Q4 | $1.08M | Buy |
6,058
+1,671
| +38% | +$297K | 0.69% | 24 |
|
|
2024
Q3 | $866K | Sell |
4,387
-248
| -5% | -$49K | 0.57% | 23 |
|
|
2024
Q2 | $795K | Buy |
4,635
+89
| +2% | +$15.3K | 0.52% | 30 |
|
|
2024
Q1 | $828K | Buy |
4,546
+875
| +24% | +$159K | 0.55% | 27 |
|
|
2023
Q4 | $569K | Buy |
3,671
+125
| +4% | +$19.4K | 0.47% | 30 |
|
|
2023
Q3 | $529K | Buy |
3,546
+74
| +2% | +$11K | 0.43% | 25 |
|
|
2023
Q2 | $468K | Buy |
3,472
+1,362
| +65% | +$184K | 0.37% | 33 |
|
|
2023
Q1 | $336K | Sell |
2,110
-47
| -2% | -$7.49K | 0.27% | 39 |
|
|
2022
Q4 | $349K | Buy |
+2,157
| New | +$349K | 0.29% | 37 |
|